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ABSTRACT 
Title: Case Management and Clinical Outcomes of People Living with HIV and Admitted to 
a State-aided District Hospital in Durban, South Africa in 2007. 
Introduction: A proportion of the many patients who have advanced AIDS in South Africa 
present for the first time requiring admission to hospital, the number of which are limited by 
the availability of beds. Novel ways were developed to offer subacute inpatient care at 
Siyaphila, a facility linked to McCord Hospital in Durban to provide expedited or immediate 
antiretroviral therapy (ART) (exposed) for patients with advanced disease before their 
discharge (ART group) . Different components of palliative care were offered for those who 
did not enter the inpatient ART programme or who were terminally ill (non-ART group) 
(non-exposed) . 
Aim: The aim of the study is to describe the clinical condition, inpatient case 
management and outcomes before discharge of people living with HIV admitted to 
Siyaphila in order to assist in developing appropriate protocols for inpatient care. 
Methods: This was an observational, analytic, cohort study using a convenience sample 
of all patients consecutively admitted to Siyaphila during nine months in 2006/2007. 
Prevalence of AIDS defining conditions at Siyaphila, time taken to progress from one 
stage of care to another and outcomes for the two groups before discharge were 
determined. Univariate and multivariate logistic regression analysis was performed on the 
ART group to identify risk factors for mortality before discharge. A comparison between 
the ART and non-ART group was also undertaken. 
Results: Among the cohort of 405 PLHIV enrolled at Siyaphila during the study period 
only 171 (42%) were initiated on ART immediately. In all patients, tuberculosis (251; 
62%) was the most common opportunistic infection followed by cryptococcal meningitis 
(68; 17%) and Pneumocystis pneumonia (28; 7%). The mean baseline CD4 cell count 
was 84 celis/uL for the non-ART group and 55 celis/uL for the ART group. (p <0.01) The 
median time from initial admission until discharge was 13 days in the non-ART group and 
18 days in the ART group. The mortality before discharge among the non-ART group was 
24% compared to 6% among the ART group. (p =0.001). The median number of days 
before ART was initiated was 14 days. Immune reconstitution inflammatory syndrome 
was diagnosed in seven patients (4%) among the admissions but caused no deaths. In 
the multivariate analysis, the odds ratio for mortality for patients under 40 years was 0.1 
(95% Confidence Interval : 0.01 - 0.9). 
Conclusions: Subacute care offered at Siyaphila provides an entry point into the ART 
programme for non-ambulatory patients who in the KwaZulu-Natal context have low ART 
uptake after discharge. The findings of this study should be adopted as the best clinical 
practice for PLHIV and AIDS admitted in the late stages of the disease. 0Nords 423) 
Title: Case Management and Clinical Outcomes of People Living with HIV and Admitted to 
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Aim: The aim of the study is to describe the clinical condition , inpatient case 
management and outcomes before discharge of people living with HIV admitted to 
Siyaphila in order to assist in developing appropriate protocols for inpatient care. 
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determined. Univariate and mUltivariate logistic regression analysis was performed on the 
ART group to identify risk factors for mortality before discharge. A comparison between 
the ART and non-ART group was also undertaken. 
Results: Among the cohort of 405 PLHIV enrolled at Siyaphila during the study period 
only 171 (42%) were initiated on ART immediately. In all patients, tuberculosis (251; 
62%) was the most common opportunistic infection followed by cryptococcal meningitis 
(68; 17%) and Pneumocystis pneumonia (28; 7%). The mean baseline CD4 cell count 
was 84 celis/uL for the non-ART group and 55 celis/uL for the ART group. (p <0.01) The 
median time from initial admission until discharge was 13 days in the non-ART group and 
18 days in the ART group. The mortality before discharge among the non-ART group was 
24% compared to 6% among the ART group. (p =0.001). The median number of days 
before ART was initiated was 14 days. Immune reconstitution inflammatory syndrome 
was diagnosed in seven patients (4%) among the admissions but caused no deaths. In 
the mUltivariate analysis, the odds ratio for mortality for patients under 40 years was 0.1 
(95% Confidence Interval: 0.01 - 0.9). 
Conclusions: Subacute care offered at Siyaphila provides an entry point into the ART 
programme for non-ambulatory patients who in the KwaZulu-Natal context have low ART 
uptake after discharge. The findings of this study should be adopted as the best clinical 
practice for PLHIV and AIDS admitted in the late stages of the disease. (Words 423) 
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1 CHAPTER 1: INTRODUCTION 
In South Africa, little is known about how the public-funded district hospitals are coping 
with the increased demand for inpatient care from the widespread epidemic of people 
living with Human Immunodeficiency Virus (PLHIV) and Acquired Immune Deficiency 
Syndrome (AIDS). Due to stigma, denial and poor socioeconomic circumstances many 
PLHIV present to hospitals in an advanced stage of illness. There are also limits to the 
number of patients who can be accommodated for initiation of antiretroviral therapy (ART) 
in outpatient clinics. Novel ways need to be found to provide access to ART for all PLHIV 
including those presenting to the hospital for admission of intercurrent opportunistic 
infections or with advanced AIDS disease who are not on ART. Early or expedited ART 
for the purpose of this study is defined as the inpatient provision of ART for Stage 4 
disease soon after diagnosis and lor management of the AIDS-related conditions during 
hospitalisation. 
The HIV and AIDS National Strategic Plan for South Africa provides framework to be 
implemented nationally and to begin to slow down the epidemic by 2011 .1 There are 
operational issues like infrastructure development and staffing around scale up which 
need development, ongoing monitoring and evaluation. 1 A proportion of patients present 
for the first time to acute care hospital services with advanced AIDS disease. Clinicians 
could use this opportunity to initiate these patients on ART. It may be difficult to do this in 
a busy acute care ward. Such patients could be transferred to a subacute care facility for 
this phase of their care. This facility could be an in-house unit linked to the acute care 
ward. There is no available literature describing this type of care for patients with AIDS in 
South Africa. The concept of subacute care wards (otherwise called step-down care) is 
supported by the National Department of Health as a way of reducing congestion in the 
acute care medical wards of hospitals. Siyaphila is an inpatient facility, which is linked to 
the acute care medical wards and offers subacute care for people living with advanced 
HIV and AIDS. Siyaphila offers a package of healthcare at lower costs than in the acute 
medical facility and incorporates a holistic care model. 
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1.1 BACKGROUND 
McCord Hospital is a State-aided district hospital in central Durban. It provides services to 
patients from Durban and surrounding areas, in KwaZulu-Natal. The hospital serves a 
population from a mixed socio-demographic background. Approximately 2400 patients 
with AIDS-related illness are admitted to the acute care medical wards at the hospital per 
year. 2 Patients who are managed at McCord Hospital pay subsidised fees for health care, 
but this is affordable only to those who have an income or who have some form of 
financial support from relatives. Patients who cannot afford fees to be admitted to McCord 
Hospital or the subacute care facility, Siyaphila, are referred to other hospitals in the 
district. 
Over the last ten years, McCord Hospital has adapted its vision to provide a 
comprehensive care plan to focus on the needs of PLHIV in the community it serves. In 
2006, approximately 50% of patients admitted to the medical wards were HIV-infected. 
The majority of these patients were admitted with World Health Organization (WHO) 
stage 4 AIDS disease.2 In 2007, the average length of stay of all patients admitted to the 
acute care medical ward was 10 days, a factor that constrained the number of new 
PLHIV that could be admitted to this already limited 45-bed ward.2 
Murphy et a/. reported high in-hospital mortality in the medical wards at McCord Hospital 
in 2006 and 2007.3 In addition; only a small proportion of those living with HIV 
commenced ART after discharge and they experienced a high mortality even after 
treatment for opportunistic infections (01), especially among those with advanced 
disease. 3 Due to the findings of this study, a new subacute care facility, Siyaphila ("We 
are well" in Zulu), was commissioned in May 2006 at McCord Hospital. The purpose of 
this facility is to offer subacute care to those who survive the initial admission with 
advanced stage AIDS-related disease. These patients often require prolonged treatment 
of their opportunistic infections and other intercurrent systemic illnesses and 
accompanying physical and psychosocial co-morbidities. These acutely ill 'survivors' are 
thus transferred from the acute care medical wards to Siyaphila. There is consequently a 
reduction in the length of stay in acute care ward and opening up of beds at McCord 
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Hospital for new acutely ill patients to be admitted . This programme enables patients to 
be managed at lower costs than in acute care medical wards.2 
Siyaphila offers a package of healthcare at lower costs and incorporates the following 
components: 
Clinical Care: Providing clinical care to PLHIV restores and maintains their immune status 
and mitigates the physical consequences of AIDS-related disease. A key component of 
clinical care is initiating PLHIV on antiretroviral therapy. 
Spiritual Care: A team competent in spiritual care addresses the major life events that 
cause people living with HIV to question themselves, their purpose and their meaning in 
life. 
Psychological Care: A psychologist and visiting psychiatrist address the non-physical 
suffering of people living with HIV and that of their family members. The team assesses 
cognitive disorders and AIDS-related dementia prior to starting ART and again after two 
months of therapy. 
Social Care: The social work team assists individuals and family members in maintaining 
linkages to and use of care, thereby preventing further HIV transmission ensuring 
adherence to treatment. Group support services are also offered to PLHIV. 
Physical Rehabilitation: Physical therapy and nutritional interventions are important 
elements of successful rehabilitation . 
End-of-Life Care: The purpose of end-of-life care is to ensure a good quality of life 
through symptom management and supportive care through the terminal phase of AIDS-
related illness in the patient and bereavement counseling for the family. 
HIV Counseling Services: A team of dedicated HIV counselors is involved in ART literacy 
training before and after ART initiation. ART literacy training is conducted in three 
sessions that involve counseling and education of patients around three key areas, 
namely, clinical aspects of HIV infection, ART adherence and the development of healthy 
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lifestyle skills. The counseling takes place with individuals and their family members 
before ART initiation. The content is similar to the counseling done in the outpatient clinic. 
There is additional emphasis on finding and training a suitable treatment supporter. As 
the patient is very ill , the first few weeks of care requires directly observed treatment even 
after the patient is discharged. 
Community Support and Follow-up: Patients who do not initiate ART at Siyaphila are 
followed up by linking them to different care providers and programmes near their place 
of residence. Clinics that provide ongoing care for PLHIV are listed on several national 
databases. Patients from the eThekwini Municipality are also referred to government or 
private sector hospitals for clinical follow up or ART initiation. 
Since May 2006, approximately 50 patients with advanced AIDS disease have been 
admitted to Siyaphila monthly for ongoing subacute care. Patients were admitted for the 
continuation of treatment of various medical conditions commenced in the acute care 
ward . Some of the patients are initiated on ART as a medical emergency shortly after 
commencing treatment for an opportunistic infection. These patients have WHO Stage 4 
disease and I or a CD4 cell count of less than 200 celis/uL, but are able to take treatment 
orally. Other patients are identified for terminal care by the palliative care team, in 
consultation with their next-of-kin. Palliative care requires time and care from a highly 
speCialised team that is based at Siyaphila.4 
From November 2006, approximately 20 patients monthly have commenced ART whilst 
admitted to Siyaphila. A system was implemented with advice from medical consultants in 
HIV and AIDS medicine at McCord Hospital. This triage system was used to assist junior 
and less experienced clinicians determine which medical inpatients could be cared for 
with subacute, but with the AIDS-specific inpatient care offered at Siyaphila. These 
patients are offered one of the two protocols of care, after informed discussion with them 
and their next-of-kin and are categorised as either a non-ART (non-exposed) or an ART 
(exposed) group. 
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(1) Non-ART group: In this group, PLHIV are offered terminal care if they have 
irreversible end-organ damage, advanced malignancies or are unable to tolerate oral 
medication for various irreversible medical reasons. The conditions for which ART 
alone is not recommended include end-stage renal disease with multiple co-
morbidities, advanced malignancies (Kaposi's sarcoma. lymphoma, cancer of the 
cervix) , intractable cardiac failure with cardiomyopathy, pulmonary hypertension with 
poor prognostic features; severe soft tissue sepsis, and complicated central nervous 
system infections with a poor prognosis. A proportion of patients were not offered ART 
as they lived outside the eThekwini municipality or had insufficient funds to afford the 
cost of at least a two-week inpatient stay in the hospital. These very sick PLHIV were 
referred to other ART sites of their choice for further care. 
Some patients in the non-ART group are offered palliative care depending on their 
clinical condition during hospitalisation. The different aspects of palliative care include 
ongoing treatment of the presenting infection, pain and symptom management and 
psychosocial support specifically addressing the needs of PLHIV. For successful 
AIDS management, a combination of disease specific and palliative care therapies are 
required . "Palliative care in AIDS is defined as supportive care that improves the 
quality of life and involves an interdisciplinary team of biomedical and psychosocial 
care providers".4 A palliative care plan for each patient ideally begins at the time of 
diagnosis of a potentially fatal illness or at the time of first contact, and continues 
together with disease specific care and throughout life. Effective disease specific 
treatment includes the treatment and prevention of opportunistic infections and use of 
ART where appropriate. In addition, symptom control and alleviation may improve the 
outcome of those living with HIV related disease and reduce their mortality. If the 
patient deteriorates clinically despite medical care, the terminal care is offered to 
those with irreversible medical conditions. 
(2) ART group: This group of PLHIV and AIDS admitted to Siyaphila received ongoing 
care of treatable, concomitant clinical conditions. Patient care was further improved by 
expedited commencement of ART before discharge. These PLHIV were initiated on 
ART at Siyaphila based on the clinical and social criteria advocated in the 2004 
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Department of Health HIV/AIDS Treatment Guidelines and had WHO Stage 4 disease 
and recorded a CD4 count <200 celis/uL. 1 
In addition, certain Siyaphila specific criteria have to be adhered to.2 For inpatient 
ART initiation these PLHIV should reside in the greater Durban area or eThekwini 
Municipality, disclose their HIV status to at least one person who could then be a 
treatment supporter (especially as most patients were non-ambulatory), be able to 
swallow pills and afford the cost of admission to Siyaphila for at least two weeks. 
1.2 AIM AND OBJECTIVES OF THE RESEARCH 
The aim of the study is to describe the clinical conditions, inpatient case management 
and outcomes of a cohort of people living with HIV, who were admitted for subacute care 
to Siyaphila during nine months in 2006/2007. 
The objectives of the study are: 
1) To describe the demographic and disease profile of PLHIV admitted to Siyaphila; 
2) To measure the inpatient prevalence of AIDS-defining conditions in people living with 
HIV adults admitted for subacute care to Siyaphila; and 
3) To compare clinical outcomes of the ART (exposed) and non-ART (non-exposed) 
group at the time of discharge of this cohort of PLHIV from Siyaphila. 
1.3 SUMMARY OF CHAPTER 
The two types of subacute care offered at the Siyaphila inpatient facility at McCord 
Hospital involve ART for those recovering from acute opportunistic infections (ART 
group), or different aspects of palliative care for those not eligible for ART for a range of 
medical and other reasons (non-ART group). In this model of care, patients that are very 
ill with HIV and AIDS could continue to receive inpatient care until commencement of 
ART becomes a viable therapeutic option for them. 
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2 CHAPTER 2: LITERA TURE REVIEW 
2. 1 INTRODUCTION AND PURPOSE OF REVIEW 
There are no guidelines or published reports of how patients are managed in step down 
care units for patients living with HIV. The Siyaphila model of subacute care seeks to 
combine best practice guidelines from different systems of inpatient care and incorporate 
them with a policy of expedited ART initiation for very ill patients. The review of the 
literature begins by describing different systems of inpatient care, and then focuses on 
specific guidelines for ART initiation with different opportunistic infections. Most of the 
systems of care reported describe inpatient management of PLHIV requiring ART in 
different clinical settings in South Africa and other low-income countries. Other studies 
reviewed give guidelines for the timing of ART initiation, early after diagnosis of an 
opportunistic infection that has been conducted in outpatient settings. Similar principles of 
early ART initiation can be operationalised in the inpatient programme at Siyaphila. 
Several studies have been conducted recently in South Africa to assess the role of ART 
in PLHIV after diagnosis of an opportunistic infection.5, 6 These reports have filled a gap 
in our understanding that studies in high-income countries failed to achieve.? The 
incidence of opportunistic infections varied in different countries and many of these 
studies did not include the opportunistic infections more commonly occurring in South 
Africa . In all these studies, ART was the medical intervention that consistently 
demonstrated the most dramatic improvement among those treated as inpatients and 
surviving AIDS.B, 9, 10 
Some studies that examine the provision of ART in the outpatient setting have reported 
poor outcomes because of delayed initiation of ART generally in any setting for various 
reasons. 11 , 12, 13 In countries where ART demand has exceeded supply, significant pre-
ART mortality has occurred among PLHIV awaiting ART. These deaths were related to 
late entry of the patient into care, a factor that may have been due to patient related 
factors , health system delays, or inappropriate treatment criteria and protocols.12 The 
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lessons learnt from such studies can be applied in such a way to the inpatient model of 
care to improve the outcomes due to delayed ART initiation. The principles of successful 
expedited inpatient ART initiation that have been described in this review has been 
operationalised in the Siyaphila model of care. This is the reason why the literature 
review is written in its current format and content. 
2.2 STUDIES ABOUT SYSTEMS OF INPA TIENT ART CARE 
Criteria for the implementation of expedited ART initiation were outlined in the South 
African Clinicians Society Journal and in the national "Comprehensive Care, 
Management and Treatment plan", in January 2009. 11 The guidelines set out which 
patients qualified for urgent ART. The document recommends that all HIV infected 
patients should be offered a clinical staging of their disease and CD4 count assessment 
at the first visit. Hospitalised and all TB patients should have this assessment within one 
week of CD4 count testing. Patients that need expedited ART could include all adults with 
a CD4 < 100 celis/uL, all adults with unexplained fever and ongoing loss of weight, all 
pregnant women qualifying for ART and all adults recently hospitalised with an HIV-linked 
condition, including TB. This group of very ill patients admitted to a hospital has been 
reported to present with unique challenges to clinicians when considering initiating 
treatment. Co-morbid illnesses, potential drug interactions, drug toxicities, immune 
reconstitution inflammatory syndrome (IRIS) and high pill burdens have been reported to 
complicate management and have to be taken into consideration.12 In such cases, it has 
been recommended that ART be commenced only after treatment for the opportunistic 
infection has been commenced. Some of the factors described above that could 
contribute to adverse outcomes after ART initiation have to be managed before 
discharge. This will require a short stay in the wards after ART initiation. 
The consequences of delayed initiation of ART in patients admitted to an acute care ward 
were investigated by Murphy et al. at McCord Hospital in Durban between December 
2006 and August 2007.3 The study was a prospective evaluation of ART uptake 
(secondary outcome) and mortality (primary outcome) six months after acute admission 
of PLHIV for an opportunistic infection. At discharge patients with an AIDS-defining illness 
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or CD4 count <200 celis/uL were urged to seek outpatient ART. All patients underwent a 
readiness to initiate ART education programme, and were assisted in locating clinics 
where they could obtain ART. The opportunistic infection recorded among the 50 patients 
enrolled was tuberculosis in 65% of the patients (pulmonary 29%, extra pulmonary 29%, 
meningitis 8%), Pneumocystis pneumonia (8%), chronic diarrhoea (8%), bacterial 
pneumonia (8%), cryptococcal meningitis (6%) and toxoplasmosis (4%). Among the 25 
patients (50%) who did not initiate ART, 13 died within six months (mortality 52%). 
Patients with the most advanced disease (CD4 count <50 celis/uL) were least likely to 
initiate ART by 6 months. This pilot study was undertaken in a group that was similar to 
that under investigation in this study. The pilot study group could thus be characterized as 
a historical control group for this study. Recommendations made in this pilot study by the 
authors, who include the researcher, prompted the creation of the inpatient model of care 
at the McCord Hospital - Siyaphila subacute care centre. This study emphasized the 
urgent need for creating inpatient systems and defining criteria for expedited ART access 
for people living with HIV and AIDS. 
In 2007, Jameson described the use of an in-patient palliative care unit in Grahamstown 
to care for patients discharged with AIDS from an acute inpatient ward.8 The palliative 
care unit was accessible to patients suffering from cancer and AIDS. Palliative care 
measures together with the provision of ART were shown to reduce the death of patients 
with AIDS admitted to the palliative care medical unit. In the first three months, 51 
patients were admitted to the inpatient unit. Of these patients, 36 (70%) had AIDS. All the 
AIDS patients had stage four diseases, and all but three were on ART. While the number 
of patients was low, it provided an indication of a discernible trend that the mortality in 
AIDS seemed to be dropping. This may have occurred because ART was being 
introduced earlier in the very ill patients. The duration of stay in the ward was longer for 
AIDS patients, and it appears that AIDS patients who survive needed a longer stay in the 
palliative care unit than cancer patients for their outcomes to improve did. The study was 
the first in South Africa to report the use of ART among inpatients although ART was 
commenced before admission. This study furthermore inspired the need to explore how 
early to introduce ART in an inpatient unit, which remains an important subject. 
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The principles of the expedited care outlined above were implemented in various 
inpatient settings. These are described in many different inpatient settings. To evaluate 
outcomes in patients commencing ART after opportunistic infection treatment during 
hospitalisation , Eshun-Wilson et al. undertook a matched case-control study at a South 
African academic hospital in Cape Town between January 01 , 2004 and March 31 , 
2008.5 Controls were selected from patients attending the infectious diseases outpatient 
department during the same period. Cases were selected from among those patients 
admitted to the acute care ward. They were initiated on ART as in patients. There was a 
high risk of loss to follow up in hospitalised patients. Previous studies by Brinkhof et al. 
had suggested that up to 50% of patients who were lost to follow-up in low-resource 
settings had died. 13 Hospitalised patients who returned for follow-up and remained on 
ART however, had favourable treatment outcomes, as seen also in a study by Soria et al. 
14 Both studies have small sample sizes making it difficult to generalise the findings . 
However, it was possible to have good virological outcomes and adherence in this group 
of patients commencing ART during hospitalisation. It appeared that a good system of 
follow up improved outcomes. Patients who do remain in care after discharge from the 
wards have a comparable treatment outcome to those of more clinically stable patients 
seen in the outpatient setting. An improved system for patient follow-up and earlier 
initiation of ART was a recommendation of these studies, a measure designed to improve 
outcomes in hospitalised patients in these settings. 
A retrospective study by Croda conducted in Brazil on 278 HIV-infected patients admitted 
to a Brazilian intensive-care unit (ICU) between 1996 and 2006 showed that 80% had 
AIDS-defining conditions, with the most common opportunistic infections being 
tuberculosis and Pneumocystis pneumonia.1o Mortality was high in both the ICU (55%) 
and six months after admission (69%). After adjustment for potential confounders, the 
use of ART in the ICU (whether initiated during admission or previously) was associated 
with a 50% reduction mortality at 6-months. The benefit was statistically significant only if 
ART was commenced within the first 4 days after ICU admission. The rate of IRIS that 
was detected in the ICU was quite low (-1 %), but this may be related to the difficulty of 
identifying IRIS in critically ill patients or from data collected retrospectively. In this study, 
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mortality was reduced in the first month after ART initiation, an outcome that suggested 
that, in the setting of acute and severe opportunistic infections, early ART might help to 
prevent additional opportunistic infections and to control the presenting opportunistic 
infection. Although confounding could not be ruled out in this retrospective studies, the 
study contributed to a growing body of evidence supporting the benefits of early ART in 
patients with acute opportunistic infections, including those admitted to leu in low income 
countries. 
The community-based programmes like that operating in Keiskamma in South Africa, has 
ART service nodes linked to community health centres. This inpatient ART programme, 
as described by Hofmeyer et al.9 is located in a 20-bedded renovated house. The centre 
provided early ART to the sickest patients who were not able to access ART in the 
hospital-based programmes. The principles of care were similar to that given to patients 
who were able to have access to a hospital for management of acute complications. 
Those who had an opportunistic infection were first treated in the centre where possible. 
Patients left the centre soon after they had started ART. Bed ridden patients (71/174, 
42%) with low Kanofskys score were likely to be sicker and likely to have a higher 
mortality. Although more patients that are bedridden died, (31 /71 , 43%) compared to 
ambulant patients (5/103, 5%) the outcome was still considered successful as these 
patients were extremely ill on commencing therapy and before the ART had a therapeutic 
effect. The success of the programme was ascribed to having an inpatient facility where 
expedited ART counseling could be conducted and patients prepared for commencing 
ART. 8 This study also provided evidence that no one should be regarded as too sick to 
access ART. 
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2.3 EVIDENCE FOR TIMING OF ART INITIATION AFTER ACUTE 
CARE OF OPPORTUNISTIC INFECTIONS 
How "early" was early ART initiation? This decision seemed to depend on the type of 
opportunistic infection with which the patient presented. Immediate initiation of ART is 
recommended for some opportunistic infections for which no specific therapy had been 
shown to be effective. 15, 16, 17 These conditions include cryptosporidiosis, certain 
microsporidioses, Kaposi's sarcoma and progressive multifocalleukencephalopathy. For 
some infections caused by highly drug-resistant pathogens such as multi-resistant herpes 
simplex virus, immediate initiation of antiretroviral therapy was warranted. 14 In another 
study by Morris et al., inpatients with severe Pneumocystis pneumonia, showed improved 
survival with early ART initiation.18 
Two recent randomized trials, by Zolopa et al. and by Karim SA et al. also supported the 
use of early ART within sixteen days and eight weeks respectively in patients with acute 
opportunistic infections.6, 7 In both trials, the benefits of early ART were apparent within a 
period of six months. The ACTG study looked at opportunistic infections for which 
directed therapy was available, and whether antiretroviral therapy should be deferred 
until the opportunistic infections had been substantially treated or not. The study 
examined survival among patients with acute opportunistic infections, randomly assigned 
to early antiretroviral therapy (initiated within 16 days of starting acute opportunistic 
infection treatment), versus deferred antiretroviral therapy (6 to 12 weeks later). A benefit 
arising from early initiation of ART was reported in patients with Pneumocystis 
pneumonia, cryptococcal meningitis and toxoplasmosis. 7 Notably, this study of 
predominately North American patients excluded persons with tuberculosis, a disease 
that remains a low-incidence opportunistic infection in the United States of America. 
To address the question of when to commence treatment in patients with TB, a recently 
completed randomized, controlled clinical trial by Karim et aI, from South Africa was 
conducted.6 This study suggested that initiating antiretroviral therapy currently with-
tuberculosis therapy was also superior to deferral of ART until TB therapy had been 
completed. Data from this study in Durban recommended starting ART early (within 2 
12 
months) after initiation of anti-tuberculosis treatment irrespective of CD4 count.6 The ideal 
timing of initiation of ART to maximize benefit and minimize morbidity and mortality 
remains unclear but has appeared to be within weeks rather than months of initiating anti-
tuberculosis treatment. These studies demonstrated conclusively that the presence of an 
opportunistic infection including TB was not an absolute contraindication to start ART 
early. Managing AIDS and TB as twin diseases and providing ART as soon as possible 
will affect the way patients are managed in the wards. Many patients are admitted to the 
wards with disseminated TB and will greatly benefit from an inpatient ART programme.6 
Another common opportunistic infection in Southern Africa is cryptococcal meningitis.2o 
Delaying ART because of concern about IRIS in these patients had resulted in fatal 
outcomes, as reported by Bicanic et al. in 2000.21 A randomized study also by Bicanic et 
al. in 2008, showed that AIDS progression or death was lower with early initiation of ART 
after opportunistic infection than with delayed initiation of therapy.21 The incidence of 
IRIS was not increased in those who started ART sooner. It is difficult to predict which 
patients had a higher mortality among the group not treated with early ART and those 
treated with ART after antifungal treatment was completed. The inability to accurately 
prognosticate did not cause clinicians to shy away from initiating ART once the patient 
had been stabilized on antifungal therapy, particularly because delaying ART could have 
fatal consequences. The South African HIV Clinicians Society guidelines recommended 
that clinicians initiate ART between 2 and 4 weeks after starting amphotericin-based 
treatment, as described by Desdric et a/.22 This recommendation is a reasonable 
approach until ongoing trials provide more evidence about the best way to stagger these 
two lifesaving therapies. Treatment with amphotericin has to be combined with the 
appropriate management of raised intracranial pressure. 
In summary, there is evidence that ART can be safely and effectively given to all severely 
ill patients irrespective of their presenting opportunistic infections. 
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2.4 THE CHALLENGE OF EARL Y ART IN THE SICKEST PA TIENTS. 
Antiretroviral therapy could complicate the clinical scenario by introducing ART-related 
drug toxicities and drug-drug interactions between ART and antimicrobial therapy 
prescribed for the opportunistic infection. The WHO report 12 noted that alterations in 
renal and hepatic function related to the acute opportunistic infection distort ART 
pharmacokinetics such as metabolic clearance, volumes of distribution, reduced 
antiretroviral efficacy and increased antiretroviral toxicity. Acute gastrointestinal 
opportunistic infections decreased antiretroviral drug absorption, producing serum levels 
that only partially suppressed HIV RNA and thereby generated selection pressure 
favoring the emergence of antiretroviral drug resistance.12 Providing ART was thus only 
the first step in providing quality care, as these patients required close monitoring in the 
wards post-ART initiation and after discharge to manage these complications of therapy. 
2.5 SUMMARY 
Several in-patient models of care have been described but none in a district hospital. The 
pathway of care that was followed in different inpatient settings has been described. The 
pertinent findings from the survey can be summarized in the following facts. A delay in 
ART initiation after discharge results in high early mortality. Patients admitted to a 
palliative care ward after being initiated on ART had better outcomes compared to other 
terminally ill patients. The National Department of Health guidelines for expedited ART 
initiation will be difficult to implement for a large number of outpatients. The inpatient 
group who is very ill will benefit most if the programme is implemented before discharge. 
There is a high proportion of loss to follow among very ill patients discharged from the 
medical wards after ART initiation. Therefore, a system of follow up to retain such 
patients in care is warranted . Commencing ART within four days of admission to an ICU 
reduced inpatient and six-month mortality. No one should be considered too sick to 
access ART, as directly observed treatment in a ward can be successfully given. To 
achieve this there is a need for better follow up and supervision of these patients to 
detect and manage early complications in the wards. 
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3 CHAPTER 3: METHODS 
3.1 INTRODUCTION 
The study used an observational, descriptive, and retrospective study design and was 
conducted in 2006/2007 at McCord Hospital. The study involved the retrospective 
analysis of data from a large number of inpatients who were offered expedited ART 
initiation. In 2006, a prospective pilot study described a similar patient population in the 
wards of McCord Hospital who were discharged from the wards without ART and 
followed up for six months after the diagnosis of an AIDS-related opportunistic infection.3 
A high mortality was recorded in this group and so it was not appropriate or ethical to 
conduct a randomized study. In most of the studies 5, 8, 9 investigating mortality after ART 
initiation in a hospital ward among very ill patients the data, as in this study, was collected 
retrospectively. 
The aim of the study was to describe the clinical condition , inpatient case management 
and outcomes of PLHIV admitted during nine months in 2006/2007 considered sick 
enough to be admitted to a district hospital but transferred for subacute inpatient care, in 
order to assist in developing protocols to manage the unprecedented burden placed on 
the acute care medical wards by the HIV and AIDS epidemic in Durban. The McCord-
Siyaphila facility that offers subacute care for PLHIV is linked to the acute care medical 
wards, and was designed as a step-down management facility for patients from acute 
care wards. 
3.2 STUDY SETTING 
The study setting was the McCord - Siyaphila facility in Durban, which is, located about 
three kilometers from McCord Hospital. Siyaphila has 42 beds and is a well-equipped and 
modern medical care facility. Doctors from the Department of Medicine at McCord 
Hospital work at Siyaphila on a four-month rotation . There is a multidisciplinary team of 
carers including social workers, psychologists, nutritionists, nurses and doctors on site. 
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They provide holistic care for PLHIV, sick enough to be considered for admission to a 
hospital. A specialist family physician with expertise in AIDS care medicine leads the 
team together with a doctor trained in palliative medicine. A range of categories of nurses 
including professional and other nursing staff categories provide nursing care at 
Siyaphila, which is also linked to an antiretroviral therapy outpatient treatment site at 
McCord Hospital.2 These patients are transferred to Siyaphila from the acute care 
medical wards and managed by the same practitioners. No patients are admitted directly 
to Siyaphila from other hospitals or clinics. 
3.3 STUDY POPULATION AND SELECTION 
The study population consisted of patients living with HIV who were transferred from the 
acute care medical wards at McCord Hospital to Siyaphila for ongoing subacute inpatient 
care for various AIDS-related clinical conditions. 
3.3.1 Sampling 
The study sample was a convenience sample consisting of all patients consecutively 
transferred from the acute care medical wards at McCord Hospital to Siyaphila during a 
nine-month period . 
3.3.2 Inclusion Criteria 
All patients older than 18 years of age who were living with HIV and AIDS who were 
transferred from the acute care wards at McCord Hospital to Siyaphila were included in 
the study population. 
3.3.3 Exclusion Criteria 
Those excluded from the study population were patients less than 18 years of age and 
who were pregnant. Pregnant patients requiring inpatient care were admitted into the 
prevention of mother to child transmission (PMTCT) programme in the antenatal wards. 
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3.4 DATA MANAGEMENT 
3.4.1 Data source and collection 
The source of data was obtained from a retrospective record review. Data was extracted 
from the hospitals electronic database and inpatient clinical records. All data were 
entered onto a data collection sheet by research volunteers and checked by the principal 
investigator. The completed data collection forms were examined for completeness of 
data entry before handing over for data entry into the electronic database. 
The data fields collected for each patient included: 
- Demographic data; 
- CD4 count at time of admission to Siyaphila; 
- Date of admission to McCord Hospital , date of diagnosis of and type of opportunistic 
infection or medical problem; 
- Dates of admission to Siyaphila, of initiation of ART, and of discharge; 
-In the case of the death of a patient, the cause of death recorded in the patient 
record or at the regular hospital mortality reviews were entered; and 
- The type of care given and / or management plan , namely: 
o Terminal care and death; 
o ART initiation and early complications; and 
o Discharge home, to a local ART clinic or another institution. 
3.4.2 Statistical Processing. 
3.4.2.1 Descriptive Statistics: 
Numerical data was categorised. An Excel spreadsheet and Access database was used 
to record all relevant data. The following measures were summarised and presented.;. 
1. Prevalence of different types of opportunistic infections and AIDS-related illnesses; 
2. Prevalence of different patient outcomes after admission to Siyaphila; 
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a. Terminal care and death 
b. ART initiation at Siyaphila 
c. Early drug related complications 
d. Discharge home without ART 
e. Discharge to local clinic for ART or TB treatment 
f. Transfer to another institution 
g. Refused hospital treatment 
3. Cause of death; 
4. Duration of inpatient stay for different clinical conditions; and 
5. Time to initiation of ART for different conditions. 
3.4.2.2 Analytical statistics: 
A mUltivariate logistic regression analysis was performed among patients who initiated 
ART as inpatients. The outcome used in the model was 'death prior to discharge'. First, a 
univariate regression analysis was performed including the following covariates: gender; 
age; baseline CD4 cell count; presence of cryptococcal meningitis (versus other 
opportunistic infections); baseline albumin; baseline haemoglobin and time between 
hospital admission and ART initiation (less than 14 days from admission versus greater 
than 14 days). Next a multivariate logistic regression model was constructed that included 
age and gender and other variables associated with a p value of <0.05 in the univariate 
regression model. For each variable in the multivariate model an odds ratio and 95% 
confidence interval was calculated. Finally, a comparison was made between the two 
groups (those who initiated ART as inpatients and those who did not receive ART after 
diagnosis of an acute opportunistic infection) for baseline characteristics and mortality 
outcome. 
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3.5 VALIDITY AND BIAS 
3.5.1 Measures to ensure validity of data 
The principal investigator assisted by some volunteer research assistants carried out data 
collection. The consistency of data collection was ensured by using a customised data 
collection sheet. 
3.5.2 Reduction of bias 
3.5.2.1 Selection bias: 
All patients admitted consecutively from the acute care medical wards who were 
considered sick enough to be sent to Siyaphila were included in the study population. 
These patients were selected for transfer to Siyaphila based on standard criteria 
described in the standard operating procedure of Siyaphila. 2 The time of transfer of 
patients with different opportunistic infections was determined by standard treatment 
guidelines for treatment of opportunistic infections, recognized by HIV medicine clinicians. 
15, 17, 19 
3.5.2.2 Information bias: 
Data was validated by triangulating it from different sources in the hospital database 
before it was entered onto the patient data collection sheet. Double entry of all data was 
the standard practice for this study. The data entered onto two separate databases was 
manually checked and verified. 
3.6 ETHICS AND PERMISSIONS 
There was no patient contact during the collection of data. All collated data was 
anonymous as no unique patient identifiers were entered into the database. Information 
linking patients to the forms were kept in a separate site from the research data, 
confidentiality of the patients was maintained and privacy was guarded as the data 
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collection sheets were in a locked cabinet in the McCord Hospital research office. 
3.6.1 Institutional ethics review board 
The research project was registered for a 33% research project for a Master of Public 
Health degree with the Postgraduate Education Committee at the Faculty of Medicine, 
University of KwaZulu-Natal. 
An application to the McCord Hospital Research Ethics committee was made and ethical 
approval granted (Appendix 1). A letter was sent to the committee regarding the change 
of title of the study. 
An application to the University of KwaZulu-Natal Biomedical Research Ethics Committee 
was approved (Appendix 4). After review by the Postgraduate Education Committee, the 
protocol was submitted with a revised title. 
3.6.1.1 Permission 
A letter of authorization from the head of McCord Hospital has been obtained (Appendix 
2). 
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4 CHAPTER 4: RESUL TS 
4.1 INTRODUCTION 
In Chapter 4, the results of the data are summarised and analysed using appropriate 
descriptive and analytic biostatistics. The baseline characteristics of the entire cohort are 
described .The outcomes in the ART (exposed) and non-ART (non-exposed) groups are 
compared. The timing of ART initiation and outcome of those initiated on ART is 
described. The risk factors associated with in-hospital mortality in the ART group are 
presented in the univariate and multivariate analysis. 
4.2 BASELINE CHARACTERISTICS OF THE ENTIRE COHORT 
Four hundred and thirty two patients were admitted to McCord Hospital with AIDS and 
referred for subacute care to Siyaphila. From this group 405 (94%) were evaluated for the 
possibility of commencing inpatient ART, and 171 (42%) of these were initiated on ART 
soon after transfer to Siyaphila (Figure 1).The median age of those admitted for subacute 
care was 38 years. There were more men (55%) than women (45%) in the cohort. The 
majority (76%) of patients had had a CD4 count of less than 100 cells/uL. Only 9% of 
these PLHIV had a CD4 count >200 cells/uL. The median CD4 count for those who had 
this measure recorded was 28 cells/uL. (Table 1) 
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432 Referred for 
immediate ART 
27 ART -experienced 
(6%) ~ 
405 Evaluated for 
immediate ART (94%) 
171 initiated early ART 
(42%) 
160 Survived to 11 Died during 179 Survived to 
discharge (94%) inpatient ART (6%) discharge (76%) 
234 did not initiate 
early ART (58%) 
55 Died priol 
discharge (24%) 
Figure 1: Flow of all patients admitted to Siyaphila from the McCord Hospital 
acute medical wards from December 2006 to August 2007 
22 
Table 1: Baseline characteristics of PLHIV admitted to Siyaphila for subacute care from November 
2006 to August 2007 (N=405) a 
Demographics 
Median age (years) [lOR) 
Women no. (%) 
Ethnicity No. (%) 
Black 





Median baseline CD4 count (cells/uL) [lOR) 
Baseline CD4 cell count category (%) b 
0-49 cells/uL 
50-99 cells/uL 
1 00-199 cells/u L 
200-349 cells/uL 
Median baseline haemoglobin (g/dL [lOR) C 
Median baseline albumin (g/l) [lOR) d 
a. 27 patIents were already on ART on admIssIon 













9.7 (7.6-11 .3) 
22 (17-27) 
c. Haemoglobin not available for 46 patients. (Normal values - Male: 11 - 14 g/dL Female: 10- 12 g/dL) 
d. Albumin not available for 86 patients. (Normal values - 25 - 35 g/dL) 
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4.3 COMPARISON BETWEEN THE ART AND NON ART GROUPS 
405 (94%) were ART na·ive and thus evaluated for the possibility of commencing inpatient 
ART. Only 171 (42%) of these were initiated on ART soon after transfer to Siyaphila 
(Figure 1). The rest (234,58%) were not considered for ART for a number of irreversible 
medical and socio-economic reasons. 
The ART group had a mean CD4 count of 55 celis/uL and the non-ART group 
(comprising 234 PLHIV) had a mean CD4 count of 84 celis/uL (p<0.01). Other baseline 
characteristics in both groups were similar. 
The exposed and non-exposed groups had a similar proportion of opportunistic 
infections. The mortality before discharge from Siyaphila was four times lower in the ART 
group (11/171,6%) compared to the non-ART group (55/234, 24 %) (p< 0.05) (Table 2). 
A Significantly higher proportion of the patients who did not initiate ART during their 
inpatient stay died, compared to only the patients who initiated ART. This is despite the 
non-ART group having a higher mean CD4 count on admission. The median length of 
admission for patients who did not initiate ART was 13 days (mean 16 days). 
Cryptococcal meningitis was the leading cause of death (15 out of 55 deaths; 27%) in the 
non-ART group. Out of 45 patients with cryptococcal meningitis in the non-ART group, 15 
(33%) died whereas only two of 23 patients (9%) with cryptococcal meningitis in the ART 
group died (Table 2). 
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Table 2: Characteristics and outcomes of the ART (exposed) and non-ART (non-exposed) groups in 
the cohort of PLHIV admitted to Siyaphila between November 2006 and August 2007 
ART GROUP- NON-ART TOTAL-405 
171 GROUP -234 
Median age [lOR] 37 [32-46] 38 [32-35] 
Women no. (%) 83 (49) 99 (42) 182 (45) 
Ethnicity no. (%) 
Black 160 (93) 218 (93) 378 (93) 
Indian descent 5 (3) 2 (1) 7(2) 
"Coloured" 4 (2) 4 (2) 8(2) 
White 0 2 (1) 2(0.5) 
Not recorded 2 (1) 5 (3) 7(2) 
Mean baseline CD4 count (celis/uL) 55 84 
p<0.01 
Median baseline CD4 count (celis/uL) [IOR]1 25 [10-78] 31 [13-105] 
Baseline CD4 cell count category no. (%) N=322a 
0-49 celis/uL 113 (70) 99 (62) 212(66) 
50-99 celis/uL 15 (9) 18 (11) 33(10) 
100-199 celis/uL 27 (17) 21 (13) 48(15) 
200-349 celis/uL 7(4) 22 (14) 29(9) 
Median baseline hemoglobin (g/dl) [lOR] 9.3 [7.9-11 .1] 9.9 [7.4-1.5] 
a.83 did not have baseline CD4 counts recorded 
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Table 2 (continued) 
ART GROUP- NON-ART TOTAL-405u 
171 (%) GROUP-234 (%) 
(%) 
Acute 01 or complication no. (%) n=146 N=234 N=380 
Pulmonary tuberculosis 60 (42) 74 (31) 134(35) 
Extra pulmonary tuberculosis 28 (19) 89 (38) 117(31) 
Cryptococcus meningitis 23 (16) 45 (19) 68(19) 
Pneumocysfis jiroveci pneumonia 15 (10) 13 (6) 28(7) 
Chronic diarrhoea (>14 days) 6 (4) 2 (1) 8(2) 
Toxoplasmosis gondii 5 (3) 1 (0.5) 6(2) 
HIVassociated nephropathy 3 (2) 2 (1) 5(1 ) 
Kaposi 's sarcoma 3(2) 4(2) 7(2) 
Other C 3(1 ) 4(2) 7(2) 
Outcomes at discharge 
Early mortality prior to discharge no. (%) 11 (6) 55d (24) 
p<O.OO1 
Mortality from cryptococcal meningitis 2/23 (9%) 15/45(33%) 
Discharged home no. (%) 160 (94) 179 (76) 
b. Baseline opportunistic infection not available In 25 patients. (N IS 405 - 25 = 380) 
c. Other opportunistic infections were Candida oesophagitis (n=2) and herpes zoster (2) in the non- ART. In 
the ART group Lymphoma (2) and cardiomyopathy (1) were listed. 
d.15/55 deaths (27%) in the non-ART group were due to cryptococcal meningitis. 
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4.4 OUTCOMES IN THE ART GROUP 
In the ART group the median duration from time of initial admission for PLHIV to the 
acute care medical ward to ART initiation was 14 days (IQR 11-19 days).The median 
duration of stay from initial admission to the acute care medical ward for PLHIV until 
discharge from Siyaphila was 18 days (lOR 15-25 days). Almost half (51%) of the 
patients were initiated on ART within two weeks from the time of their initial admission to 
the hospital. The time to initiate ART in only 28 patients (18%) was more than three 
weeks. Almost all the patients started on regimen 1A (Stavudine, Lamivudine, Efavirenz). 
Eight patients experienced adverse events as inpatients soon after commencing ART and 
one patient died of drug induced hepatitis. IRIS was diagnosed in 4% of patients (n =7) 
post ART but caused no deaths. IRIS was related to pulmonary tuberculosis (1), extra 
pulmonary tuberculosis (2) and cryptococcal meningitis (2). In two cases, the 
opportunistic infection associated with IRIS was not recorded. Six percent (11/171) 
patients who initiated ART at Siyaphila died during the inpatient stay. Among the 11 
patients who died in the ART group, pulmonary tuberculosis was the cause of death in 
three, extra pulmonary tuberculosis in three and cryptococcal meningitis in two of the 
deaths. One case each was recorded as being caused by HIV associated nephropathy 
HIV cardiomyopathy, and lymphoma. 
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Suspected IRIS events during inpatient ART initiation, no. (%) 7(4) 
Underlying opportunistic infection among patients with IRIS b 
Pulmonary tuberculosis 1/7 
Extra pulmonary tuberculosis 2/7 
Cryptococcal meningitis 2/7 
Deaths among patients with suspected IRIS syndrome 0(0%) 
Total deaths during inpatient ART initiation ~ 
Deaths, no. (%) 11 (6) 
Median days to death after ART initiation (n=11) - no. [lOR] 10 [3-17] 
Adverse events during inpatient ART initiation (N=171) 
Hepatitis. no. (%) 5 (3) 
Renal insufficiency. no. (%) 3 (2) 
Deaths among patients with suspected adverse event d 1 (1%) 
b. Opportunistic infection was not recorded In two patients who developed a serious IRIS event 
c. Pulmonary tuberculosis (n=3) , extra pulmonary tuberculosis (n=3) , cryptococcal meningitis (n=2) , 
HIVassociated nephropathy (n=1), HIV-associated cardiomyopathy (n=1) , and lymphoma (n=1) . 
d. One patient died with hepatitis after ART initiation resulting from drug toxicity 
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Table 3: Outcomes among PLHIV enrolled for early inpatient ART (exposed group) at Siyaphila from 
November 2006 to August 2007 (N=171) 
Outcomes Patients 
Timing of ART initiation 
Median duration (days) of total admission- [lOR] 18[15-25] 
Median days from initial ward admission to ART initiation [IOR]a 14 [11-19] 
Days from initial ward admission to ART initiation, No. (%) 
0-7 days 10 (6) 
8-14 days 70 (45) 
15-21 days 47 (31) 
>21 days 28 (18) 
TOTAL a 155 (100) 
ART regimens initiated no, (%) 
D4T - 3TC - EFV 168 (98) 
D4T - 3TC - NVP 2 (1) 
Regimen 3A 1 (1) 
TOTAL 171 (100) 
a. In 16 patients, total length of stay not recorded 
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4.5 TIME TO ART INITIATION AFTER DIAGNOSIS OF DIFFERENT 
OPPORTUNISTIC INFECTIONS 
Among the different opportunistic infections, the mean time to ART initiation from initial 
admission to McCord Hospital was 15 days for those with pulmonary TB and extra 
pulmonary TB. Patients with cryptococcal meningitis started ART after a mean of 19 
days. Those with Pneumocystis pneumonia and chronic diarrhea commenced ART after 
16 days. The longest mean time taken for ART initiation was 21 days for the five patients 
with Toxoplasmosis of the brain (Table 4). The mean time from admission to the acute 
care ward to ART initiation in the subacute care ward in all patients was 16 days. Time 
taken from admission to the acute care ward at McCord hospital for all infections to 
discharge from the Siyaphila subacute care ward was 21 days. 
Table 4: Outcomes by opportunistic infection among PLHIV commenced on ART at the Siyaphila 
from November 2006 and August 2007 
Opportunistic Infection N lTime from admission to Time from admission to 
~RT(median/mean days) • discharge(median/mean days) 
All infections a 137 14/16 18/21 
Pulmonary tuberculosis 60 13/15 17/20 
Extra pulmonary TB 28 12/15 17 /19 
Cryptococcal meningitis 23 18/19 22/24 
P. jiroveci pneumonia 15 16/16 19/21 
Chronic diarrhoea 6 16/16 19/20 
Toxoplasmosis gondii 5 ~1/21 25/25 
Other infection D 3 13/13 18/17 
a.171 enrolled (34 excluded from analysIs of time taken): 25 had no clearly recordable Ols and 9 excluded 
from this analysis: Kaposi 's sarcoma (n=3) , HIV associated nephropathy (n=3) , HIV-associated 
cardiomyopathy (n=1) and lymphoma (2) 
b. Candida oesophagitis (1) and herpes zoster (n=2) 
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4.6 RISK FACTORS FOR MORTALITY IN THE ART GROUP 
Table 5: Factors associated with mortality during early exposure to inpatient ART initiation 
(exposed group) at Siyaphila from November 2006 to August 2007. 
Characteristics Univariate Inpatient mortality Multivariate .' 
Odds Ratio 
N no. (%) p value· (95% CI) 
All patients 171 11 (6 
Female 83 5 (6 
Male 88 4 (6 0.83 0.9 (0.2 - 4.8) 
Age a 
~ 40 years 63 8 (13) 
< 40 years 90 2 (2) 0.02 0.1 (0.01 - 0.9) 
Opportunistic infection (01) 
Cryptococcal meningitis 23 2 (9 
Other 01 148 9 (6 0.63 
CD4 cell count at initial ART failure (celis/uLt 
~50 49 5 (10) 
< 50 113 5 (4 0.17 0.3 (0.05 - 1.3 
Albumin" 
~ 20 gIL 104 5 (5 
< 20 gIL 51 5 (10) 0.24 1.3 (0.2 - 7.0 
Hemoglobin U 
~ 10 mgldL 65 3 (5, 
< 10 mgldL 101 8 (8, 0.5€ 
Days between admission and ART initiation e 
> 14 days 75 7 (9) 
0-14 days 80 3 (4, 0.17 0.4 (0.07 - 2.5 
a,b,c,d,e Missing data for categories: - due to incompletely filled information on the patient files andlor 
electronic records. 
In the univariate analysis, the characteristics of patients initiating ART who did not survive 
to discharge were compared with those who survived (Table 5). In the univariate model, 
gender, baseline cryptococcal meningitis, CD4 cell count, albumin, haemoglobin and 
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days between admission and ART initiation were not predictive of very early mortality. 
There was a significant relationship between the age of the patient when ART was 
initiated and mortality before discharge. Patients 40 years and older experienced higher 
premature mortality compared with those less than 40 years (13% versus 2%, P < 0.05). 
The mean age of patients beginning ART who died prior to discharge was 48.2 years 
compared to 38.7 years among those who survived (P <0.05). 
A multivariate logistic regression analysis was performed only among patients who 
initiated ART as inpatients with the outcome variable being death prior to discharge. 
Covariates included gender, age, baseline CD4 cell count and presence of cryptococcal 
meningitis (versus other 01), albumin level, haemoglobin level and delay prior to ART 
initiation (less than 14 days from admission versus greater than 14 days). For each 
variable, odds ratios and 95% confidence intervals were calculated. Variables associated 
with viral suppression were included in the multivariate model. Potential interactions 
between variables were assessed by stratification, and combining terms in logistic 
regression analyses. The odds ratio for mortality for patients <40 was 0.1 (95% CI: 0.01 
to 0.9) indicating that there was a significant protective effect for younger age patients 
commencing immediate ART in this group. 
4.7 SUMMARY. 
The average CD4 count is lower in patients admitted with an AIDS defining illness. There 
is a wide range of opportunistic infections that are common in PLHIV admitted to hospital. 
Tuberculosis, cryptococcal meningitis, Pneumocystis pneumonia and toxoplasmosis, are 
common in patients with low CD4 counts. The prevalence of these infections was 
tuberculosis (62 %), cryptococcal meningitis (17%) and Pneumocystis pneumonia (7 %). 
Expedited ART was successfully provided at Siyaphila. Forty two percent of the patients 
were initiated on ART during the inpatient stay. The mean duration of stay for the entire 
group in Siyaphila after transfer from the acute care medical wards was 18 days. The 
median time from diagnosis of opportunistic infection in the acute care ward to 
commencement of ART at Siyaphila was 14 days. 
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ART can be safely initiated early to inpatients with T8 and Cryptococcal meningitis. There 
were a small number of adverse events and IRIS cases reported. Immune Reconstitution 
Inflammatory Syndrome was an early (within one week) manifestation in only 5% of 
patients but none of these patients died. There was only one death in the exposed group 
due to drug-induced liver toxicity after ART initiation. The patients that benefited most 
from ART before discharge appear to be those with cryptococcal meningitis and 
Pneumocystis pneumonia There were only 2/23 (9%) deaths for cryptococcal meningitis 
in the ART group compared to 15/45 (33%) in the non-ART group. 
Patients in the ART group had a lower CD4 count and a lower mortality and this was 
statistically significant. Among the patients who did not initiate ART prior to discharge the 
mortality was 24 %( 55/234) but only six percent (11/171) among those who initiated 
ART. (p<0.001). 
Age over 40 years was associated with significant mortality and PLHIV who have Stage 4 
disease were found to be mostly younger (mean age of 38 years) . 
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5 CHAPTER 5: DISCUSSION 
5.1 INTRODUCTION 
In the Siyaphila group, the initiation of ART occurred within two weeks for most 
opportunistic infections, including TB when the patient is admitted to hospital. The results 
of this retrospective study also supports the findings of published randomized control 
trials done in South Africa like the "SAPIr' trial for early initiation of ART(within eight 
weeks) in patients admitted with TB-HIV co-infection. 6 The timing for ART initiation after 
the diagnosis and treatment of TB in this study on 405 patients conducted at the McCord 
Siyaphila Centre was on average of two weeks. From the CAMELIA trial 23 done in 
Cambodia there is the growing body of evidence indicating that earlier ART in TB co-
infection (within 14 days) is better. The CAMELIA study was done in 661 H IV-infected , 
ART-naive patients with smear-positive TB and CD4 counts <200 celis/uL (median, 25 
celis/uL) . The analysis of early versus late ART in SAPiT 6 is still pending, but one 
wonders whether simultaneous initiation of HIV and TB treatment could reduce early 
mortality rates even further. 
Although there is increasing evidence that earlier initiation of ART may lead to reduced 
morbidity and mortality, multiple co-morbid illnesses, drug interactions, drug toxicities, 
IRIS and high pill burden complicates the management of this special group of patients. 
To implement expedited ART for patients presenting with acute opportunistic infection 
(and almost by definition advanced AIDS), prolonged hospitalization of PLHIV may be 
required to surmount the considerable barriers discussed. In South Africa, the care of 
these patients could be ideally implemented as an inpatient ART programme. The results 
of the Siyaphila programme demonstrate that early ART can be safely and efficiently 
initiated among patients admitted to acute medical wards. 
This discussion focuses on key lessons learnt about case management of different 
opportunistic infections among patients admitted to a district hospital in Durban. Although 
McCord Hospital is a semi-private, state-aided hospital, the disease profile among 
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patients with stage four AIDS is similar to patients admitted to any district hospital in 
KwaZulu-Natal. The results of this study can contribute to further evidence to guide best 
practice guidelines for the public health challenges in treating large numbers of PLHIV as 
hospital inpatients. 
5.2 CASE MANAGEMENT OF ALL THE PATIENTS ADMITTED TO THE 
SIYAPHILA 
We describe the case management of PLHIV requiring hospital admission. The Siyaphila 
programme offers a critical additional entrance point into care for typically non-ambulatory 
patients with advanced disease who have been shown under routine conditions to have 
low ART uptake after discharge.3 The majority of patients presented with critically low 
CD4 counts (two thirds below 50 celis/uL). A recent study in the academic hospital in 
Cape Town recommended that an improved system of inpatient initiation and earlier 
initiation of ART and follow up be required to improve outcomes in hospitalized HIV-
infected patients. 5 The study done at the Siyaphila Centre of McCord Hospital resonates 
with this recommendation. The value of this inpatient subacute care programme is that it 
is linked to an acute care ward so that ART initiation can be immediate .The programme 
is also linked to the outpatient ART clinic of the hospital so that follow up can be 
appropriately managed by the same medical team. 
Tuberculosis co-infection contributes the largest burden of disease and was diagnosed in 
two thirds of all admissions. Other common presenting infections were cryptococcal 
meningitis, Pneumocystis pneumonia, toxoplasmosis of the brain and chronic diarrhoea. 
Clinicians will need to prioritise care plans for these patients based on best practice and 
latest evidence as discussed in the recommendations. 
5.3 MANAGEMENT OF THE INPATIENT ART GROUP 
Forty-two percent of patients out of the group that were evaluated for immediate ART 
were found to be eligible to start ART as inpatients. This evaluation was based on 
biomedical and psychosocial criteria for ART readiness.2 These patients commenced 
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ART after treatment for the intercurrent HIV-linked condition within a median of two 
weeks from date of initial admission to the hospital. This time falls within the 
recommended timelines set by the national guidelines for expedited ART initiation. 1o 
Among the eight (5%) patients initiated on ART at Siyaphila who died during the in-
patient stay tuberculosis (6) and cryptococcal meningitis (2) was reported the leading 
cause of death. This reflected the high prevalence of these opportunistic infections in 
PLHIV who present in an advanced stage of illness. IRIS was diagnosed in 5% of 
patients post-ART commencement but was not a cause of mortality. These results 
demonstrate that the early ART mortality due to IRIS is low and should not preclude any 
patient from qualifying for expedited ART initiation. 
Patients with cryptococcal disease also benefited from early ART initiation within the 
Siyaphila programme as intravenous amphotericin antifungal therapy was provided as 
standard of care. Prior to the availability of ART, the prognosis of patients with 
cryptococcal meningitis was observed to be very poor. 20 It should be noted, however, 
that survival in the context of ART co-administration has improved a lot. 21 Evidence from 
the USA suggest that recurrent cryptococcal disease associated with a delay in ART 
initiation is associated with equal or increased morbidity and mortality. The benefits of 
inpatient initiation of ART in the patient with cryptococcal disease are considerable and 
include the opportunity to monitor the adverse renal and haematological complications of 
amphotericin B therapy. The benefit of a longer inpatient stay is seen in patients who 
started on two weeks of amphotericin B for cryptococcal meningitis as they could be 
counseled on adherence to therapy during hospitalization, initiated on ART before 
discharge and brought back to the clinic early. 
The median total duration of stay in Siyaphila after transfer from the acute care medical 
wards for all patients in the ART group was 18 days (mean stay - 21 days).Most patients 
stayed for a median of four days after the ART initiation. This was crucial to monitor and 
treat anticipated adverse events and drug toxicities from combined opportunistic infection 
treatment and ART. The variable time to initiate ART after initial admission for different 
clinical conditions emphasizes the need for an individualized approach to determine the 
36 
optimal time to initiate ART. Different conditions and clinical presentations require 
different durations of treatment for the presenting opportunistic infection. Those patients 
that have associated physical and psychosocial co-morbidities require a longer time of 
ART readiness preparation. 
Age, independent of CD4 cell count and other baseline factors, may be an important risk 
factor for very early (inpatient) mortality after ART initiation with the spectrum of 
opportunistic infections found in Durban. Age increased likelihood of death through 
several mechanisms including presence of co-morbid disease, greater frequency of 
adverse drug events or through other pathways not yet well understood. It is important to 
note that older patients still clearly benefited from inpatient ART initiation with a survival 
to discharge of 55 (87%) of 63 patients among those ~ 40 years. Nonetheless, we 
recommend more vigilance during ART initiation in this patient group when an 
opportunistic infection is present. 
5.4 COMPARISON OF THE ART AND NON-ART GROUP. 
Fifty eight percent of patients discharged from the acute care medical wards to the 
Siyaphila Centre did not initiate ART during their admission. Seventy six percent of this 
non-ART group were discharged home or for follow-up at other institutions. The HIV-
linked condition for which they were admitted was managed and ART readiness training 
was provided for them. 
Twenty four percent of the patients who did not initiate ART died during their inpatient 
stay at Siyaphila. They died soon after admission due to terminal medical conditions as 
they presented in an advanced stage of illness .The causes of death in these patients 
were mainly due to tuberculosis and cryptococcal meningitis and reflect the high 
prevalence of these conditions on admission of this group. The mortality before discharge 
from the Siyaphila Centre was five times lower in the ART group (6%) compared to the 
non-ART group (24%) and this was statistically significant. There appears to be an early 
inpatient survival benefit for patients starting ART within two weeks of being admitted with 
an 01. Patients in the non-ART group were not initiated on ART because of many clinical 
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reasons and personal reasons. Those patients, who were terminally ill , were unable to 
take oral medications and had lower CD counts. Other patients in this group had 
relatively higher CD4 counts and were eligible for ART at Siyaphila. They chose to 
receive treatment elsewhere, were not yet willing to start ART as inpatients or were not 
able to afford the cost of the inpatient stay. These factors would have contributed to a 
higher mortality (despite the higher mean CD4 count) in the non-ART group. 
Cryptococcal meningitis was the single leading cause of death in the entire non-ART 
group in the 15 out of 55 deaths (27%). Thirty three percent (15/45) patients with 
cryptococcal meningitis died in the non-ART group. This disease seems to benefit 
significantly from early ART initiation as soon as treatment for the infection has been 
completed. There were only two deaths (2/23,9%) from cryptococcal meningitis among 
the ART group.(Table 2) Male patients were more numerous in this programme as more 
males were eligible for the ART initiation according to the criteria for admission to the 
programme. 
5.5 LIMITATIONS OF THE STUDY 
The study was conducted in 2007 and since then the policy for early counseling and 
testing has been revised . The national HIV counseling and testing has replaced the 
voluntary counseling and testing strategy in 2010.24 This could improve the health 
seeking behavior of patients and many could access care earlier before serious clinical 
deterioration. The new guidelines 24 also provide ant tuberculosis therapy at higher CD4 
counts. «350 cells 1 uL) With this strategy, the mortality from tuberculosis could be 
significantly reduced. It will be valuable to study how the new guidelines have affected 
mortality among this group of patients. However where patients do still present late for 
care, the immediate initiation of ART can reduce mortality significantly. 
A limitation of this study is that follow-up data was not available after discharge on 
patients initiated on ART during admission to the Siyaphila Centre. However, the 
proportion of early complications identified during this in-patient ART programme was 
very low. There is also a clear survival benefit in those PLHIV starting ART soon after 
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diagnosis of their opportunistic infections. In addition, we have seen, based on research 3 
done on patients who did not enter the Siyaphila subacute care programme that up to a 
third of patients discharged after opportunistic infection and not commenced on ART 
would not have survived six months without the opportunity of prolonged inpatient care, 
including the provision of ART. 
The Siyaphila programme is site specific to a subacute care unit. Not all aspects of this 
programme can be generalisable to all inpatients settings. However, the principles of care 
can be applied judiciously to any programme. One criticism we anticipate is that this 
programme cannot be scaled up because of cost. However, we predict cost savings in 
the end, because patients receiving ART will avoid incurring the high personal and 
societal costs of repeated hospitalisations, which typically characterize the life history of 
patients with advanced HIV and AIDS disease. Although the inpatient ART programme 
was associated with a cost, the cost of inpatient care at Siyaphila is actually considerably 
lower than the daily costs in an acut~are ward . We would recommend formal costing of 
the programme to determine cost per disability-adjusted life year averted. The Siyaphila 
model of care provides a high quality of clinical care in a subacute step-down facility that 
is likely to be at less cost than acute care due to reduction in level of staff required for 
implementing such a programme. 
Medium and long-term adherence to ART among very sick patients in this cohort is also 
not known. We propose to explore this in ongoing research based from the Centre. 
Mortality and morbidity studies in the cohort have not been compared to the programme 
in outpatient settings. The comparison has also not been made with other inpatient 
programmes like palliative care units. However, the principles of palliative care for AIDS 
patients have been successfully implemented at Siyaphila. 
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6 CHAPTER 6: CONCLUSIONS AND RECOMMENDA TIONS 
Lessons learnt about the principles of inpatient care from the published literature and the 
recommendations for the timing of ART from other studies need to be included in these 
recommendations. The Siyaphila programme will also provide lessons that can be 
applied to various inpatient settings. Recommendations will be made for the development 
of protocols of care for various opportunistic infections and for guidelines to develop step 
down care facilities linked to district hospitals. 
6. 1 CONCLUSIONS 
6.1.1 CASE MANAGEMENT OF PLHIV ADMITTED TO A DISTRICT HOSPITAL 
Average CD4 count is lower in patients admitted with AIDS defining illness. There is a 
wide range of opportunistic infections that are common in the wards. Tuberculosis, 
cryptococcal meningitis , Pneumocystis pneumonia and toxoplasmosis, are common in 
patients with low CD4 counts. One important challenge linked with providing an optimal 
service for patients are the unique needs that each patient brings to the therapeutic 
encounter and the need for individualised attention. Tuberculosis co-infection contributes 
the largest burden of disease and was diagnosed in two thirds of all admissions. 
Clinicians will need to prioritise care plans for these patients based on best practice and 
latest evidence as discussed in the recommendations. Starting ART as soon as it can be 
tolerated after anti-tuberculosis therapy will be of great benefit in reducing mortality. 
6.1.2 INPA TIENT ART PROGRAMME 
The guidelines described about timing of ART initiation in the Siyaphila programme 
correlate closely with recommendations from the published literature. These patients 
commenced ART after treatment for the intercurrent HIV-linked condition within a median 
of two weeks from date of initial admission to the hospital. This time falls within the 
recommended timelines set by the national guidelines for expedited ART initiation.11 
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It is important to note that older patients still clearly benefited from inpatient ART initiation 
with a survival to discharge of 55 (87%) of 63 patients among those ~ 40 years. 
Nonetheless, we recommend more vigilance during ART initiation in this patient group 
when an opportunistic infection is present. 
The median total duration of stay in Siyaphila after transfer from the acute care medical 
wards for all patients in the ART group was 18 days (mean stay - 21 days). The variable 
time to initiate ART after initial admission for different clinical conditions emphasizes the 
need for an individualized approach to determine the optimal time to initiate ART. Most 
patients stayed for a median of four days after the ART initiation. This was crucial to 
monitor and treat anticipated adverse events and drug toxicities from combined 
opportunistic infection treatment and ART. 
6.1.3 PA TlENTS WHO WERE NOT ELIGIBLE FOR ART 
For this group care was provided with the use of a multidisciplinary team that embraced 
holistic medical care and palliative care. An attempt was made to individualise and 
optimize patient care and outcomes among PLHIV. Patients in this group did not access 
ART for various reasons. This approach did not preclude the use of palliative care for 
terminally ill patients with adequate bereavement counseling and support with their 
families. Some patients who did not enter the programme were prepared for ART 
initiation and disbursed to other sites. The mortality among the patients with cryptococcal 
meningitis was high as reported in other studies. The patients with severe neurological 
complications and those in whom amphotericin antifungal therapy was contradicted 
generally have a very high mortality. Providing less nephrotoxic antifungal therapy and 
cost of care for these inpatients for prolonged periods remains a challenge. 
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6.2 RECOMMENDA TIONS 
6.2.1 Number 1 
This study provides the basis for developing protocols for step down care in patients with 
advanced HIV disease. Clinicians trained in HIV medicine at McCord Hospital provided 
the recommendations for when to start ART after different types of opportunistic 
infections. These recommendations were based on published reports and guidelines for 
care.25 The outcomes of this study as crucial pilot data combined with existing reports on 
best practice and recommendations by the South African HIV Clinicians Society 11 can 
form the basis for developing protocols. We think these recommendations can form the 
basis for further discussions of a more broadly adopted model of step down care for 
advanced HIV patients in South Africa. 
6.2.2 Number 2 
The Siyaphila model of care has operationalised early ART initiation described in large 
randomised trials reported in this paper. This retrospective analysis of inpatient care to 
provide early ART after 01 diagnosis in 2006 and 2007 was commenced before the 
results of other trials were out. The programme was commenced because of the urgency 
of the need to reduce the mortality among this group of inpatients. 
Based on evidence in the literature and best practice, the following guidelines are 
suggested for when to initiate ART after diagnosis of an acute opportunistic infection. 
a) Pulmonary and extra pulmonary tuberculosis: Begin ART once the patient has 
demonstrated no early adverse effect of tuberculosis therapy as early as one week 
after TB treatment initiation. 
b) Cryptococcal meningitis: Amphotericin B is recommended for at least 14 days with 
monitoring for renal dysfunction and haematological toxicity (anaemia) prior to 
initiation of ART. 
c) Pneumocystis pneumonia: After a week of acute treatment, which generally will 
include corticosteroids and high dose cotrimoxazole, ART is recommended as 
early as one week after PCP therapy initiated. 
d) For all other AIDS associated opportunistic infections and associated illnesses, 
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begin ART within a week of opportunistic infection diagnosis. 
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Patient Data Collection Form 
Date form Completed (ddlmrntyyyy): Completed by: 
SlJdy ID number: 
Date of wart! admission (ddfmrntyyyy): 
Date of birth: (ddlmrntyyyy) 
Gender. r Female r Male Ethnic Group: r Black r While r Indian 
Dt!!l!!O!I, of OIlM,d.CJI' Problem; 
OpportunIstic Inf,ctlon; 
r PLAmooary lb 
r Tb Monlngllls 
Extra poJmonsry 1b 
r (not 1b meningitis) 
rpcp 
r Cryptooooool Moningill:l 
r OIarmea ~ 14 days 
r Herpes lostor 
r Esophageal candidiasis 
r TOKO gondil 
r Kaposi's Sarcoma 
rlRIS 
r Recurrent Pneumonia 
r Ronol Failure 
r Cort!11IO Failure 
r CAC.".." 
r Lympnoma 
r ARV Complication 
r UwrTo"lclty (1B Drugs) 
r PML 











CMV of any organ other 
r than 1lIoef, spleen or LN 
r H~I associated dementia 
r HN associated wasting 
Basallna blood tast 
Latest CD4 count: 
lalest Viral load: 
Latest Hb: 
LatastAlb: 
Date of admission to Slyaphlla: 
Date of commencement of ARVs: 
MY Regimen: r 3TCJ04T/EFV 
r 3TClD4TINVP 
r AZT/3TC EFZ 
r AZT/3TC1NVP 




at Siyaphlla (If any): r Hepatitis 
r Rarel Failure 
... _. -.. --,.. .. -.. ~ .... 








r Renaf FallU1t 
r Neuropsychiatric Compllcallons (EFV) 
rather 
Date Terminal Care Commenced (ddlmmIWYY): 
Outcom'; r Death 
r RHT/Abscmded 
r Discharge 
Refenal to local dlnlc for: r Ttl 
rARVa 
Referral for ongoing care to: r HBCW 
r The Dream Centra 
Comments: 
8.4 Appendix 4 
25 A"!Iust 2009 
Dr H Sunpoth 
Ik: Cord Hospi tal 
28 Mc Cord Road 
Overport 
~7 
De.J r Or Sunpa~h 
;'\1 
4·" •• • 11/ ., 
UNIVERSITY Of 
KWAZULU-NATAl 
elO/l\COtUl I[$O=-CM (TltCS AD.~ISTR.o\TOJ 
a,..ulWTtI Off'-' . w"",*# '-lmCU 
w.t.n~I BuAd~ 
hMI:. lag ;lt 5 ... ]01 
Our1»r, 
.'" Itw .. lI .. . HbU t, SOUTH AFRO. 
TI'4 :;7 3116J.o"1· f' ;u: 2J .11 l.oo.~ 
Wt"t~'t.e : hup. ' ut;u ... h A.;n.;M;U / I!::~~~~~·~ttKt.;~ 
PROTOCOL: Us. MMlag.m.nt and Ctinicol OUtcom.s 01 Pati..,ts Ivins with 
HIV/AIdo and admitted to a State-aided Hospital In Durban, South Afria In 2009_ 
Dr H Sunpath_ IIEI46109_ 
EXPEDITED APPLICATION 
A ,ub-ccmmittee of the Biomedical R""""ch Ethics Committee has consi_ed and 
noted you- application received on 16 Julv 2009_ 
The study Wl> approved pending appropr1at. responses to 'l\l"r16 ratsed. Your 
res:xnses dated 17 Au!ust 2009 to queries ",ised on 12 A"!Iust 2009 have bftn nctld 
by • sub-committee oi the Biomedical Research Ethics Committee. Tne conditions 
hove now hPP.n met and ftvo study is lIiven fuU .. thlei opl><onl IIld may Ileain os from 
today; 25 AlJ!IL'Sl 2009. 
Thi. aPPl uva l is va Ud 10f '"'" year from 25 AU!IUst 2009. To eruure ..-.interrupted 
.pprOll.1 of this Sludy beyond the approval ""plry date, an .ppUuli .. , lUI 
recertification must be submitted to eRE( on tho appropnate BREC form 2-3 months 
befcre the eJqJiry date. 
Any amendments to t his study, lJ1leos§ lW'!pnt ly rPQu1r!'d to ensure safetf of 
participants, must be approved by BREC prior to Imp(Qmentation. 
YOU! acC.,plallce or t hi' aoproval denot .. your canplionce with South "fri can National 
Research Ethic< GuidQIint's (200A), SOUth AIr1cM National Good Clinical Prac t ice 
GuidcUn", (2006) (if applicable) ond with UKZN BREC ethk s reqUlrEme'ltS a. containod 
In the UKZN BREC Terms of Rererence and Standard Operating Procedure;, all 
(lviIIlIahlp a t hni1: / ! rpCFfll'f'h Ilk"l1 a t: ;::~ l R~e6lf hEthiC) 11 4 ' 5.d"R? 
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BREC Is regislered with the South Africiln National Health Research Ethics Council 
(REC-290408-009) . BREC has US Office for Human Research Protections (OHRP) 
Federal-wide ASsurance (FWA 678). 
The sub-committee's dedsion will be RATlFIED al a full sitting of the Biomedical 
Research Ethics Committee meeting to be held on 08 September 2009. 
We wish you well with this study. We would appreciate receiving copies of all 
publications arising out of this study. 
Yours sincerely 
./ I .... " 
t i ' L:.~------....' A J L C' L--c.. _____ 
Professor D.R Wassenaar 
Chair: Biomedical Research Ethics Committee 
r 
, 
I 
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